Fadel A. Sharif & Hadeer N. Abuwarda. (2023) Autoimmunity and re-expression of cancer/testis antigens: Numerous disorders one mechanism hypothesis. Medical Hypotheses 171, pages 111019.
Crossref
Sepideh Dashti & Zahra Taherian-Esfahani. (2020) Cellular immune responses against cancer-germline genes in cancers. Human Antibodies 28:1, pages 57-64.
Crossref
Leonardo Mirandola, Maurizio Chiriva-Internati, Robert Bresalier, Francesco M. Marincola, Jose A. Figueroa & Scott Dahlbeck. (2019) Preliminary report of a novel formulation of clinical-grade, fully matured, tumor-associated peptide-loaded dendritic cells for cancer immunotherapy. Translational Medicine Communications 4:1.
Crossref
Soudeh Ghafouri-Frad, Mahnaz Seifi-Alan, Roshanak Shamsi & Ali Esfandiary. (2015) Immunotherapy in Multiple Myeloma Using Cancer-Testis Antigens. Iranian Journal of Cancer Prevention 8:5.
Crossref
Lei Wang, Nan Jin, Anita Schmitt, Jochen Greiner, Georg Malcherek, Michael Hundemer, Jiju Mani, Dirk Hose, Marc S Raab, Anthony D. Ho, Bao-an Chen, Hartmut Goldschmidt & Michael Schmitt. (2015) T cell-based targeted immunotherapies for patients with multiple myeloma. International Journal of Cancer 136:8, pages 1751-1768.
Crossref
Kwong Y. Tsang, Caroline Jochems & Jeffrey Schlom. 2015. Developments in T Cell Based Cancer Immunotherapies. Developments in T Cell Based Cancer Immunotherapies
1
27
.
T. Ghadban, D.R. Perez, Y.K. Vashist, M. Bockhorn, A.M. Koenig, A.T. El Gammal, J.R. Izbicki, U. Metzger, F. Hauswirth, D. Frosina & A.A. Jungbluth. (2014) Expression of cancer testis antigens CT10 (MAGE-C2) and GAGE in gastrointestinal stromal tumors. European Journal of Surgical Oncology (EJSO) 40:10, pages 1307-1312.
Crossref
Surinder S. Sahota, Natalia Savelyeva, Debora Joseph-Pietras, Niklas Zojer & Jason Rice. 2013. Advances in Biology and Therapy of Multiple Myeloma. Advances in Biology and Therapy of Multiple Myeloma
73
110
.
Ross Brown, P. Joy Ho, John Gibson & Douglas Joshua. 2013. Advances in Biology and Therapy of Multiple Myeloma. Advances in Biology and Therapy of Multiple Myeloma
3
24
.
Joanna Zaleska & Krzysztof Giannopoulos. (2012) Immunotherapeutical approaches for multiple myeloma. Acta Haematologica Polonica 43:1, pages 68-74.
Crossref
Otavia L. Caballero & Yao-Tseng Chen. 2012. Innate Immune Regulation and Cancer Immunotherapy. Innate Immune Regulation and Cancer Immunotherapy
347
369
.
Maurizio Chiriva-Internati, Leonardo Mirandola, Marjorie Jenkins, Martin Cannon, Everardo Cobos & W Kast. 2011. Cancer Vaccines. Cancer Vaccines
126
139
.
Maurizio Chiriva-Internati, Leonardo Mirandola, Marjorie Jenkins, Martin Cannon, Everardo Cobos,W. Martin Kast. 2011. Cancer Vaccines: From Research to Clinical Practice. Cancer Vaccines: From Research to Clinical Practice
126
139
.
Christoph Schlude & Philipp Beckhove. 2011. Multiple Myeloma. Multiple Myeloma
97
109
.
Fu-ling Zhou, Shan Meng, Wang-gang Zhang, Yong-chang Wei, Xing-mei Cao, Gai-gai Bai & Bai-yan Wang. (2010) Peptide-based immunotherapy for multiple myeloma: Current approaches. Vaccine 28:37, pages 5939-5946.
Crossref
Otavia L. Caballero & Yao-Tseng Chen. (2009) Cancer/testis (CT) antigens: Potential targets for immunotherapy. Cancer Science 100:11, pages 2014-2021.
Crossref